Quinapril and Eylea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Quinapril (quinapril hydrochloride) and Eylea (aflibercept). Common drug interactions include gastrointestinal haemorrhage among females and cataract among males.

The phase IV clinical study analyzes what interactions people have when they take Quinapril and Eylea. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Quinapril?

Quinapril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 12,927 Quinapril users. Check the latest studies of Quinapril.

What is Eylea?

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.

On Jul, 11, 2026

19 people who take Quinapril and Eylea together, and have interactions are studied.

What are the common drug interactions of Quinapril and Eylea, by gender? *:

female:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Visual acuity reduced (reduced clearness of vision)
Blindness transient (sudden loss of vision)
Blindness unilateral
Eye inflammation
Hypopyon (pus in the eye)
Retinal haemorrhage (bleeding from retina)
Vision blurred

male:

Cataract (clouding of the lens inside the eye)
Drug ineffective
Eye pain
Pulmonary mass
Visual acuity reduced (reduced clearness of vision)
Visual impairment
Impaired driving ability
Inflammation
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Visual pathway disorder

What are the common drug interactions of Quinapril and Eylea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Visual acuity reduced (reduced clearness of vision)
Vision blurred
Visual pathway disorder
Blindness transient (sudden loss of vision)
Blindness unilateral
Eye inflammation
Hypopyon (pus in the eye)
Impaired driving ability
Inflammation

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 36.84%
Cardiac Failure Congestive: 7 people, 36.84%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 36.84%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 4 people, 21.05%
Age-Related Macular Degeneration: 3 people, 15.79%
Pain: 2 people, 10.53%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 5.26%
Retinal Haemorrhage (bleeding from retina): 1 person, 5.26%
Retinal Aneurysm (an abnormal dilatation of an retinal artery): 1 person, 5.26%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Quinapril and Eylea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously